Cryo Cell International (CCEL) Change in Accured Expenses (2010 - 2026)

Cryo Cell International (CCEL) has reported Change in Accured Expenses for 17 consecutive years, with $79854.0 the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 104.8% year-over-year to $79854.0; the TTM figure through May 2026 stood at $1.8 million (up 254.71% YoY), while the FY2024 annual figure was $2794.0, down 99.82% from the prior year.
• Change in Accured Expenses improved to $79854.0 in Q2 2026 per CCEL's latest filing, from -$1.4 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.4 million in Q4 2023 and bottomed at -$1.9 million in Q2 2024.
• Historically, Change in Accured Expenses has averaged $47208.2 across 5 years, with a median of -$28966.0 in 2022.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 708.73% — and 2025, when it sank 28359.27%.
• Cryo Cell International's Change in Accured Expenses stood at $1.4 million in 2022, then soared by 142.47% to $3.4 million in 2023, then sank by 100.03% to -$1035.0 in 2024, then surged by 303111.98% to $3.1 million in 2025, then plunged by 97.45% to $79854.0 in 2026.
• Business Quant data shows CCEL's Change in Accured Expenses at $79854.0 in Q2 2026, -$1.4 million in Q1 2026, and $3.1 million in Q3 2025.